1921
Volume 100, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Type 2 reaction (T2R) or (ENL), a sudden episode of acute inflammation predominantly affecting lepromatous leprosy patients (LL), characterized by a reduced cellular immune response. This possibly indicates a close relationship between the onset of T2R and the altered frequency, and functional activity of T lymphocytes, particularly of memory subsets. This study performed ex vivo and in vitro characterizations of T cell blood subpopulations from LL patients with or without T2R. In addition, the evaluation of activity of these subpopulations was performed by analyzing the frequency of these cells producing IFN-γ, TNF, and IL-10 by flow cytometry. Furthermore, the expression of transcription factors, for the differentiation of T cells, were analyzed by quantitative real-time polymerase chain reaction. Our results showed an increased frequency of CD8/TNF effector memory T cells (T) among T2Rs. Moreover, there was evidence of a reduced frequency of CD4 and CD8 IFN-γ–producing cells in T2R, and a reduced expression of and . Finally, a significant and positive correlation between bacteriological index (BI) of T2R patients and CD4/TNF and CD4/IFN-γ T cells was observed. Thus, negative correlation between BI and the frequency of CD4/IL-10 T cells was noted. These results suggest that CD8/TNF T are primarily responsible for the transient alteration in the immune response to in ENL patients. Thus, our study improves our understanding of pathogenic mechanisms and might suggest new therapeutic approaches for leprosy.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.18-0517
2019-01-14
2020-01-27
Loading full text...

Full text loading...

/deliver/fulltext/14761645/100/2/tpmd180517.html?itemId=/content/journals/10.4269/ajtmh.18-0517&mimeType=html&fmt=ahah

References

  1. WHO, 2017. Global leprosy update, 2016: accelerating reduction of disease burden. Wkly Epidemiol Rec 92: 501519. [Google Scholar]
  2. Talhari C, Talhari S, Penna GO, , 2015. Clinical aspects of leprosy. Clin Dermatol 33: 2637. [Google Scholar]
  3. Cardoso CC, Pereira AC, de Sales Marques C, Moraes MO, , 2011. Leprosy susceptibility: genetic variations regulate innate and adaptive immunity, and disease outcome. Future Microbiol 6: 533549. [Google Scholar]
  4. Ridley DS, Jopling WH, , 1966. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis 34: 255273. [Google Scholar]
  5. Massone C, Belachew WA, Schettini A, , 2015. Histopathology of the lepromatous skin biopsy. Clin Dermatol. 33: 3845. [Google Scholar]
  6. Nath I, Saini C, Valluri VL, , 2015. Immunology of leprosy and diagnostic challenges. Clin Dermatol. 33: 9098. [Google Scholar]
  7. Nery JA, Vieira LM, de Matos HJ, Gallo ME, Sarno EM, , 1998. Reactional states in multibacillary Hansen disease patients during multidrug therapy. Rev Inst Med Trop Sao Paulo 40: 363370. [Google Scholar]
  8. Dos Santos LN, da Silva PH, Alvim IM, Nery JA, Lara FA, Sarno EN, Esquenazi D, , 2016. Role of TEFFECTOR/MEMORY cells, TBX21 gene expression and T-cell homing receptor on type 1 reaction in borderline lepromatous leprosy patients. PLoS One 11: e0164543. [Google Scholar]
  9. Pocaterra L, Jain S, Reddy R, Muzaffarullah S, Torres O, Suneetha S, Lockwood DN, , 2006. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India. Am J Trop Med Hyg 74: 868879. [Google Scholar]
  10. Kahawita IP, Lockwood DNJ, , 2008. Towards understanding the pathology of erythema nodosum leprosum. Trans R Soc Trop Med Hyg 102: 329337. [Google Scholar]
  11. Wemambu SN, Turk JL, Waters MF, Rees RJ, , 1969. Erythema nodosum leprosum: a clinical manifestation of the arthus phenomenon. Lancet 2: 933935. [Google Scholar]
  12. Modlin RL, Bakke AC, Vaccaro SA, Horwitz DA, Taylor CR, Rea TH, , 1985. Tissue and blood T-lymphocyte subpopulations in erythema nodosum leprosum. Arch Dermatol 121: 216219. [Google Scholar]
  13. Stefani MM, Guerra JG, Sousa AL, Costa MB, Oliveira ML, Martelli CT, Scollard DM, , 2009. Potential plasma markers of Type 1 and Type 2 leprosy reactions: a preliminary report. BMC Infect Dis 9: 7583. [Google Scholar]
  14. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A, , 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708712. [Google Scholar]
  15. Murphy KM, Stockinger B, , 2010. Effector T cell plasticity: flexibility in the face of changing circumstances. Nat Immunol 11: 674680. [Google Scholar]
  16. Silva DSD, 2018. Blood coagulation abnormalities in multibacillary leprosy patients. PLoS Negl Trop Dis 12: e0006214. [Google Scholar]
  17. Bryceson ADM, Pfaltzgraff RE, , 1990. Leprosy, 3rd edition. Edinburgh, London, Melbourne and New York: Churchill Livingstone, 240 pp.
  18. Manandhar R, LeMaster JW, Roche PW, , 1999. Risk factors for erythema nodosum leprosum. Int J Lepr Other Mycobact Dis 67: 270278. [Google Scholar]
  19. Voorend CG, Post EB, , 2013. A systematic review on the epidemiological data of erythema nodosum leprosum, a type 2 leprosy reaction. PLoS Negl Trop Dis 7: e2440. [Google Scholar]
  20. Mattos KA, Lara FA, Oliveira VG, Rodrigues LS, D’Avila H, Melo RC, Manso PP, Sarno EN, Bozza PT, Pessolani MC, , 2011. Modulation of lipid droplets by Mycobacterium leprae in Schwann cells: a putative mechanism for host lipid acquisition and bacterial survival in phagosomes. Cell Microbiol 13: 259273. [Google Scholar]
  21. Axelsson-Robertson R, Rao M, Loxton AG, Walzl G, Bates M, Zumla A, Maeurer M, , 2015. Frequency of Mycobacterium tuberculosis-specific CD8+ T-cells in the course of anti-tuberculosis treatment. Int J Infect Dis 32: 2329. [Google Scholar]
  22. Caccamo N, 2009. Analysis of Mycobacterium tuberculosis-specific CD8 T-cells in patients with active tuberculosis and in individuals with latent infection. PLoS One 4: e5528. [Google Scholar]
  23. Khamesipour A, Nateghi Rostami M, Tasbihi M, Miramin Mohammadi A, Shahrestani T, Sarrafnejad A, Sohrabi Y, Eskandari SE, Keshavarz Valian H, , 2012. Phenotyping of circulating CD8+ T cell subsets in human cutaneous leishmaniasis. Microbes Infect 14: 702711. [Google Scholar]
  24. Negera E, Bobosha K, Walker SL, Endale B, Howe R, Aseffa A, Dockrell HM, Lockwood DN, , 2017. New insight into the pathogenesis of erythema nodosum leprosum: the role of activated memory T-cells. Front Immunol 15: 1149. [Google Scholar]
  25. Surh CD, Boyman O, Purton JF, Sprent J, , 2006. Homeostasis of memory T cells. Immunol Rev 211: 154163. [Google Scholar]
  26. Terrazzini N, Mantegani P, Kern F, Fortis C, Mondino A, Caserta S, , 2018. Interleukin-7 unveils pathogen-specific T cells by enhancing antigen-recall responses. J Infect Dis 217: 19972007. [Google Scholar]
  27. Gebhardt T, Wakim LM, Eidsmo L, Reading PC, Heath WR, Carbone FR, , 2009. Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus. Nat Immunol 10: 524530. [Google Scholar]
  28. Pham D, Vincentz JW, Firulli AB, Kaplan MH, , 2012. Twist1 regulates Ifng expression in Th1 cells by interfering with Runx3 function. J Immunol 189: 832840. [Google Scholar]
  29. Sakaguchi S, Miyara M, Costantino CM, Hafler DA, , 2010. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 10: 490500. [Google Scholar]
  30. Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, Levings MK, , 2006. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 212: 2850. [Google Scholar]
  31. Chevalier MF, Didier C, Petitjean G, Karmochkine M, Girard PM, Barré-Sinoussi F, Scott-Algara D, Weiss L, , 2015. Phenotype alterations in regulatory T-cell subsets in primary HIV infection and identification of Tr1-like cells as the main interleukin 10-producing CD4+ T cells. J Infect Dis 211: 769779. [Google Scholar]
  32. Sarno EN, Grau GE, Vieira LM, Nery JA, , 1991. Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states. Clin Exp Immunol 84: 103108. [Google Scholar]
  33. Teles RM, Moraes MO, Geraldo NT, Salles AM, Sarno EN, Sampaio EP, , 2002. Differential TNFalpha mRNA regulation detected in the epidermis of leprosy patients. Arch Dermatol Res 294: 355362. [Google Scholar]
  34. Lockwood DN, Suneetha L, Sagili KD, Chaduvula MV, Mohammed I, van Brakel W, Smith WC, Nicholls P, Suneetha S, , 2011. Cytokine and protein markers of leprosy reactions in skin and nerves: baseline results for the North Indian INFIR cohort. PLoS Negl Trop Dis 5: e1327. [Google Scholar]
  35. Hussain R, Lucas SB, Kifayet A, Jamil S, Raynes J, Uqaili Z, Dockrell HM, Chiang TJ, McAdam KP, , 1995. Clinical and histological discrepancies in diagnosis of ENL reactions classified by assessment of acute phase proteins SAA and CRP. Int J Lepr Other Mycobact Dis 63: 222230. [Google Scholar]
  36. Foss NT, de Oliveira EB, Silva CL, , 1993. Correlation between TNF production, increase of plasma C-reactive protein level and suppression of T lymphocyte response to concanavalin A during erythema nodosum leprosum. Int J Lepr Other Mycobact Dis 61: 218226. [Google Scholar]
  37. Evans HG, 2014. TNF-α blockade induces IL-10 expression in human CD4+ T cells. Nat Commun 5: 3199. [Google Scholar]
  38. Esquenazi D, Alvim IM, Pinheiro RO, Oliveira EB, Moreira LO, Sarno EN, Nery JA, , 2015. Correlation between central memory T cell expression and proinflammatory cytokine production with clinical presentation of multibacillary leprosy relapse. PLoS One 10: e0127416. [Google Scholar]
  39. Farber DL, Yudanin NA, Restifo NP, , 2014. Human memory T cells: generation, compartmentalization and homeostasis. Nat Rev Immunol 14: 2435. [Google Scholar]
  40. Park CO, Kupper TS, , 2015. The emerging role of resident memory T cells in protective immunity and inflammatory disease. Nat Med 21: 688697. [Google Scholar]
  41. Stirling DP, Koochesfahani KM, Steeves JD, Tetzlaff W, , 2005. Minocycline as a neuroprotective agent. Neuroscientist 11: 308322. [Google Scholar]
  42. El-Khalawany M, Shaaban D, Sultan M, Abd Alsalam F, , 2012. Inhibition of angiogenesis as a new therapeutic target in the treatment of lepromatous leprosy. Clin Cosmet Investig Dermatol 5: 16. [Google Scholar]
  43. Garrido-Mesa N, Zarzuelo A, Gálvez J, , 2013. Minocycline: far beyond an antibiotic. Br J Pharmacol 169: 337352. [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.18-0517
Loading
/content/journals/10.4269/ajtmh.18-0517
Loading

Data & Media loading...

Supplemental Figure and Table

  • Received : 22 Jun 2018
  • Accepted : 10 Oct 2018
  • Published online : 14 Jan 2019

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error